FDA Clears J&J's Monarch Surgical Bot for Bronchoscopy

The new software release also leverages the company's open digital ecosystem.

Quest3 Ui On Monarch Monitor 03 Full System Gray Bgq1
Johnson & Johnson

Johnson & Johnson today announced U.S. 510(k) regulatory clearance for MONARCH QUEST 3, the latest software update for the MONARCH Platform.

The MONARCH Platform is a robotically assisted platform for bronchoscopy. MONARCH QUEST delivers continuous visualization during the procedure, inclusive of navigation to and biopsy of targets under direct vision, an advanced robotically-assisted bronchoscope that gives physicians precise control and stable reach, and navigation and targeting that accounts for CT-to-body divergence.

In addition to new QUEST capabilities, this release leverages Polyphonic, Johnson & Johnson’s open digital ecosystem. Polyphonic for MONARCH can help extend surgical intelligence beyond the procedure by enabling clinicians to review procedural volume data and collaborate with other teams through a centralized video library. Polyphonic for MONARCH organizes each MONARCH case into a consistent, reviewable format — making it easier to revisit procedures, identify key moments, and support learning.

MONARCH QUEST 3 is designed to deliver:

  • AI‑powered nodule segmentation, designed to automatically generate more accurate nodule boundaries with a single click during pre‑procedural planning.
  • Software enhancements to improve registration and navigation accuracy, helping clinicians maintain confidence as anatomy shifts during the procedure.
  • A new 3D Compass overlay, designed to improve visual orientation between joystick controls and patient anatomy to simplify scope‑tip orientation.
  • Broader compatibility with commonly used mobile and fixed CBCT imaging systems, enabling clinicians to leverage existing imaging infrastructure to help manage CT‑to‑body divergence and improve targeting of lung nodules.
More in Surgical